Tragically, the NIH is finding any reason it can to cancel grants, including critical research into the nature and function of mycobacterium tuberculosis. www.washingtonpost.com/science/2025...
Tuberculosis is not going away. If the cutting edge research goes away, #TB will rage on. Harvard is being targeted including the TB Immunology contract and that trickles down to all of us working on these studies. Progress will be halted. And TB will flourish. www.bostonglobe.com/2025/04/08/m...
"In the end, I have come to realize that being authentic at work is not a weakness, but rather a strength." #ScienceWorkingLife https://scim.ag/49B7hRv
Science isn’t partisan. As scientists, we dedicate our whole lives and sacrifice our time to advance understanding to save lives. Every day this administration aims to punish those whose goals aren’t self-serving.
apple.news/AAjwsLdXSRLS...
I’m so happy for my first post on Bluesky to be introducing my first 1st author paper! We show that alveolar macrophage inflammatory cytokine production to low dose LPS is enhanced by IFN-b due to lack of c-Maf/IL10 production. Download, share, and support science!! academic.oup.com/jimmunol/art...
A new White House freeze on using government-issued credit cards is the latest shock for federal scientists, potentially affecting everything from conference travel to needed purchases for clinical care or lab work. scim.ag/4hV9oRb
So happy to share our latest paper on #AlveolarMacrophage responses to low-dose #LPS led by @pamelialim.bsky.social!AM #innate responses are enhanced by IFN-beta due to low c-Maf and IL-10 expression, with implications for AM responses to respiratory infections and environmental exposure. #ImmunoSky
Cancellation of this TB "moonshot" would be devastating to the #TB research community, further reducing any chance for novel and innovative therapies to contain the global epidemic. On a personal note, I've learned so much from this amazing team. Just heartbreaking. #TBsky #Immunosky
I’m like 99% sure that mice don’t even have genders.